Symbol
|
PMWLTQ | MBBHJB | RMAZ2V | Z095OZ | Z0972Z | Z0974Z | Z0973Z | Z09GFZ |
---|---|---|---|---|---|---|---|---|
Nom | Multi Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Vonti | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look |
Sous-jacent
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Amazon.com Inc. / BNP Paribas S.A. / Daimler AG / Pfizer Inc. | Altria Group Inc. / Pfizer Inc. / Philip Morris Intl. Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / UnitedHealth Group Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | BioNTech SE / Moderna Inc. / Pfizer Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
09.02.2026 | 23.01.2025 | 09.03.2026 | 28.08.2025 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 29.04.2025 |
Ratio | - | - | - | - | - | - | - | - |
Prix d'exercise
|
24,49 | 46,928 | 37,86 | 21,2443 | 189,578 | 189,578 | 189,578 | 17,1243 |
rendement max. p.a. | - | 27,10% | - | 8,97% | 9,26% | 12,80% | 11,32% | 6,78% |
Demande | 89,51 | 90,40 | 92,20 | 96,80 | 100,00 | 101,02 | 100,56 | 101,86 |
Offre | - | 90,95 | - | 97,50 | 100,50 | 101,52 | 101,06 | 102,36 |